• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

231.73 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery
May 13, 2026
Via Investor Brand Network
Topics Intellectual Property
News headline image
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
May 12, 2026
From Johnson & Johnson
Via Business Wire
News headline image
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
From BioMedWire
Via GlobeNewswire
News headline image
Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 11, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
May 05, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
April 30, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
April 27, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
April 21, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
April 21, 2026
From Johnson & Johnson
Via Business Wire
News headline image
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
April 15, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
April 14, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
April 14, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
April 10, 2026
From Johnson & Johnson
Via Business Wire
Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
April 09, 2026
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
April 09, 2026
From AINewsWire
Via GlobeNewswire
News headline image
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
April 07, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
March 12, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion
March 05, 2026
EQNX::TICKER_START (NNASDAQ:HELP),(CBOE:HELP),(NASDAQ:ACHC),(NYSE:JNJ),(NASDAQ:BWAY),(NASDAQ:AIFF) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 02, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
February 18, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
February 17, 2026
From BioMedWire
Via GlobeNewswire
News headline image
Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
February 13, 2026
From Beasley Allen Law Firm
Via Business Wire
News headline image
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
February 10, 2026
EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
February 09, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
February 06, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
February 02, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile
January 27, 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson reports Q4 and Full-Year 2025 results
January 21, 2026
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap